AKT1 and Alzheimer disease: According to an in vitro study, MSC-derived exosomal miR-223 (when applying 2 μg exosome-based on exosomal protein content per 1 × 105 recipient cells) could target PTEN and stimulated PI3K/Akt signaling pathway in an in vitro model of AD.